Green Tea Extract Composition for Hormone Regulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for premenstrual syndrome and climacteric symptoms, such as hormone replacement therapies, often come with side effects and long-term medication risks, while existing analgesics only temporarily alleviate pain without addressing emotional anxiety or skin aging issues, necessitating a safer and more effective natural alternative.

Innovation Solution

A composition containing 4-15 wt % of (−)-gallocatechin gallate (GCG) and 4-15 wt % of (−)-epigallocatechin gallate (EGCG) in green tea extract, which is administered to prevent, alleviate, or treat female hormone regulation disorders, offering a natural, side-effect-free solution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If hormone replacement therapies are used to treat premenstrual syndrome and climacteric symptoms, then symptom relief is achieved, but side effects and long-term medication risks occur

Engineering Contradiction:
Improvesymptom relief effectivenessVSAvoidside effects and medication risks
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and utilizes specific natural compounds (catechins, flavonoids, saponins, triterpenes, sterols) from green tea and other plant sources that can alleviate hormone-related symptoms without the harmful side effects of synthetic hormone replacement therapies. This extraction of beneficial natural components resolves the contradiction by providing effective treatment while eliminating the harmful factors associated with conventional hormone therapies.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs natural plant extracts that can be safely used for extended periods without accumulating harmful effects, replacing long-term hormone medications with safer, naturally-derived alternatives that maintain effectiveness over time without the risks of long-term synthetic hormone use.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Object-affected harmful factors

If analgesics are used to alleviate pain, then pain relief is achieved temporarily, but emotional anxiety and discomfort remain unresolved

Engineering Contradiction:
Improvepain reliefVSAvoidcomprehensive symptom resolution
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent employs multi-functional plant extracts that simultaneously address multiple symptoms including pain, emotional anxiety, and hormonal imbalances. The natural compounds in the composition work on multiple physiological pathways at once, providing comprehensive relief rather than temporary pain suppression, thus resolving the limitation of single-function analgesics.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Object-affected harmful factors

If conventional treatments are used for premenstrual syndrome, then some symptoms are alleviated, but skin aging and other long-term effects are not addressed

Engineering Contradiction:
Improvesymptom alleviationVSAvoidcomprehensive health improvement
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The patent utilizes plant extracts with multiple bioactive compounds that simultaneously address acute symptoms and long-term health concerns including skin aging. The composition works on multiple physiological systems concurrently, providing both immediate symptom relief and long-term preventive benefits that conventional treatments fail to deliver.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS11633449B2Method for preventing, alleviating, improving, or treating the female hormone controlling disorder syndrome or symptoms comprising a step of administering green tea extract which has modified amounts of ingredients
Publication Date: 2023.04.25 AMOREPACIFIC CORP
  • US11633449B2 patent drawing
  • US11633449B2 patent drawing
  • US11633449B2 patent drawing

AI summary

The present disclosure relates to a method for preventing, alleviating, improving or treating female hormone regulation disorder or symptoms, which contains a green tea extract with contents of ingredients changed. Specifically, the method according to an aspect of the present disclosure includes a step of administering an effective amount of a green tea extract, which contains (−)-gallocatechin gallate (GCG) and (−)-epigallocatechin gallate (EGCG) at specific contents, to a subject in need thereof, and may exhibit an effect of preventing, alleviating, improving or treating female hormone regulation disorder or symptoms.